Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease

Figure 1

Kaplan-Meier curves for time to first dose of anti-TNF therapy stratified type of insurance drug coverage. Publicly funded subjects (solid line) experienced longer times to first anti-TNF dose than privately funded subjects (dashed line).